Announcements

Removal of Component(s) – RETA

September 20, 2023

LifeSci Biotechnology Products Index

Effective at the market close on Thursday, September 21, 2023, RETA will be removed from the LifeSci Biotechnology Products Index and its value will be redistributed to the remaining index components based on their weights.

On July 28, 2023, Reata Pharmaceuticals announced that it would be acquired by Biogen Inc. for $172.50/share in cash.